JHG vs STVN Comparison

Janus Henderson Group provides investment management services to retail intermediary (49% of managed assets), self-directed (20%) and institutional (31%) clients. At the end of June 2025, active equities (53%), fixed-income (31%), balanced (12%) and alternative (4%) investment platforms constituted the company's $457.3 billion in assets under management. Janus Henderson sources most of its managed assets from clients in North America (66%), with customers from Europe, the Middle East, Africa, and Latin America (25%) and the Asia-Pacific region (9%) accounting for the remainder.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.